Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ingenjörsfirman Gösta Schelin, Ventilationshygien Stockholm and Pactor Luftbehandling
Mandate

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ingenjörsfirman Gösta Schelin, Ventilationshygien Stockholm and Pactor Luftbehandling

March 31, 2021 Employment and Benefits M&A Real Estate and Construction

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ingenjörsfirman Gösta Schelin Aktiebolag, Ventilationshygien Stockholm AB and Pactor Luftbehandling Aktiebolag.

The companies provide services within design, installation and service linked to indoor climate and are based in Stockholm. Together, the companies have a turnover of approximately SEK 250 million. The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of partner Christina Kokko together with Karl Klackenberg, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Construction), Elin Broman (Employment) and Frida Ställborn (Real Estate).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025